Outsourcing cytological samples to a referral laboratory for EGFR testing in non‐small cell lung cancer: does theory meet practice?

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2303|956-5507|5|312-317

ISSN： 0956-5507

Source： CYTOPATHOLOGY, Vol.956-5507, Iss.5, 2015-10, pp. : 312-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anaplastic lymphoma kinase gene rearrangements in cytological samples of non–small cell lung cancer: Comparison with histological assessment

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 6, 2014-06 ,pp. : 445-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients

By  

CANCER CYTOPATHOLOGY, Vol. 121, Iss. 10, 2013-10 ,pp. : 552-560

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of EGFR mutations on gefitinib sensitivity in non-small cell lung cancer

By Suzuki Takeshi   Mitsudomi Tetsuya   Hida Toyoaki  

Personalized Medicine, Vol. 1, Iss. 1, 2004-12 ,pp. : 27-34

Future Medicine

Access to resources Recommend Favorite

The Role of EGFR-TK Inhibition in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 12, 2005-12 ,pp. : 619-620

Karger

Access to resources Recommend Favorite

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

By  

Oncology, Vol. 86, Iss. 2, 2014-01 ,pp. : 86-93

Karger

Access to resources Recommend Favorite